why choose us

First received: September 27, 2023

Clinical Trial: Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma

Study Status: Completed

Recruit Status: RECRUITING

Condition: Adrenocortical Carcinoma

Study Type: INTERVENTIONAL


Official Title: Safety and Immunological Effects of Ablative Radiotherapy Followed by Pembrolizumab in Patients With Advanced Adrenocortical Carcinoma

Brief Summary: The purpose of this study is to determine whether pembrolizumab given after standard ablative Radiotherapy is a safe treatment that causes few or mild side effects in people with advanced Adrenocortical Carcinoma.

Read more